drugset / Trial / NCT05208034

Medical Treatment in Ectopic Tubal Pregnancy

NCT05208034

Completed 100 enrolled Nishtar Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Ectopic pregnancy (EP) is estimated to be responsible for approximately 20% of all pregnancy-related mortality and 46% early pregnancy mortality.1 Hemodynamically stable women with EP are frequently managed with methotrexate (MTX) while multiple protocols like fixed multiple doses, single-dose as well as two-dose regimens have been in practice for treating EP, but no consensus exists regarding the optimum dosage regimen.

Timeline

Start
2020-01-01
Primary completion
2021-07-30
Completion
2021-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 50 mg/m2 Intramuscular

Indications